News-Morimatsu LifeSciences

FROM CRITICAL EQUIPMENT TO
TOTAL PROCESS SOLUTION

BACK

Adjuvants: The key weapon that makes modern novel vaccines stand out

01 Abstract Adjuvant, also known as an immunomodulator or immune booster, enhances the body’s immune response to an antigen or changes the type of immunity. Early in the 1920s, an abscess developed at the inoculation site when Ramon inoculated horses with diphtheria toxin, where the
Enable innovation and accomplish long-term goals with diligence: Understand 2022 interim results report of Morimatsu International in a chart

Forward-Looking Statements The information in this press release may include some forward-looking statements. Such statements
Pharmadule-Morimatsu invites you to join us at ACHEMA 2022

ACHEMA 2022 will take place at Messe Frankfurt, Germany on August 22-26, 2022. Pharmadule-Morimatsu will attend the conference to discuss new developments in the industry with industry experts on modular facilities, process systems, bioreactors and other products. At the conference, we will also pre
PAT Special Series I Status of Process Analytical Technology (PAT) in Biopharmaceutical Fields

Basic Background and History of PAT The Process Analytical Technology (PAT)initiative originated from the 2004 guidelines issued by the U.S. Food and Drug Administration (FDA) as a system for designing, analyzing, and controlling manufacturing processes through the timely measur
How to multiply the magic of the “magic bullet” ADC?

Introduction With the development of targeted therapeutic drugs, more and more drug conjugates show excellent clinical results, and the curtain of the pan-coupling era has been quietly opened. Antibody-drug conjugates (ADC), peptide-drug conjugates (PDC), small molecule-drug conjugate

Prev ···8 9 10 11 12··· Next